<DOC>
	<DOCNO>NCT00764842</DOCNO>
	<brief_summary>The purpose study evaluate survivorship efficacy Encore CLP® Hip stem group 200 patient data already collect .</brief_summary>
	<brief_title>Efficacy CLP® Hip - Retrospective</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Necrosis</mesh_term>
	<criteria>1 . Patients must 18 year age old . 2 . Noninflammatory degenerative joint disease include Osteoarthritis natural femoral head Avascular necrosis natural femoral head Rheumatoid arthritis 3 . Correction functional deformity 4 . Femoral fracture 5 . Patients must able willing complete studyrelated visit . 1 . Anyone 18 year age 2 . Infection sepsis 3 . Insufficient bone quality may affect stability implant 4 . Muscular , neurological vascular deficiency , compromise affect extremity 5 . Skeletally immature patient case loss abductor musculature , poor bone stock , poor skin coverage around hip joint would make procedure unjustifiable 6 . Osteomyelitis 7 . Rapid joint destruction bone absorption apparent roentgenogram 8 . Pathological condition acetabulum would prevent achieve proper range motion , appropriate head stability , and/or wellseated supported smooth articulation head within acetabulum 9 . Alcoholism addictions 10 . Materials sensitivity 11 . Loss ligamentous structure 12 . High level physical activity ( e.g. , competitive sport , heavy physical labor ) 13 . Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2011</verification_date>
</DOC>